ArticleJournal of pharmaceutical innovation2017

Comparing Adoption of Breakthrough and "Me-too" Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 Inhibitors.

Inmaculada Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.